Envestnet Asset Management Inc Journey Medical Corp Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 109,586 shares of DERM stock, worth $438,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,586
Previous 131,571
16.71%
Holding current value
$438,344
Previous $742,000
16.58%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DERM
# of Institutions
40Shares Held
2.94MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.46 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.3 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.26 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.07 Million0.0% of portfolio
-
American Financial Group Inc180KShares$720,0000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $46.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...